Literature DB >> 29603203

Association of interleukin 22 gene polymorphisms and serum IL-22 level with risk of systemic lupus erythematosus in a Chinese population.

R Wang1,2, Y-L Zeng2, H-M Qin1,2, Y-L Lu1,2, H-T Huang1,2, M Lei1,2, T Tan1,2, Y-Y Huang1,2, H-C Luo2, Y Lan3, Y-S Wei2.   

Abstract

The aim of this study was to investigate the association between the single-nucleotide polymorphisms (SNPs) of the interleukin 22 (IL-22) gene and systemic lupus erythematosus (SLE) in a Chinese population. Three IL-22 SNPs (rs2227485, rs2227513 and rs2227491) were genotyped using SNaPshot SNP genotyping assays and identified by sequencing in 314 SLE patients and 411 healthy controls. The IL-22 level of serum was assessed by enzyme-linked immunosorbent assay (ELISA) kits. Data were analysed by spss version 17.0 software. We found that rs2227513 was associated with an increased risk of SLE [AG versus AA: adjusted odds ratio (aOR) = 2·24, 95% confidence interval (CI) = 1·22-4·12, P = 0·010; G versus· A: adjusted OR = 2·18, 95% CI = 1·20-3·97, P = 0·011]. Further analysis in patients with SLE showed that the AG genotype and G allele were associated with an increased risk of renal disorder in SLE (G versus A: aOR = 3·09, 95% CI = 1·30-7·33, P = 0·011; AG versus· AA: aOR = 3·25, 95% CI = 1·35-7·85, P = 0·009). In addition, the concentration of IL-22 was significantly lower in the rs2227513 AG genotype compared with AA genotype (P = 0·028). These results suggest that rs2227513 polymorphism might contribute to SLE susceptibility, probably by decreasing the expression of IL-22.
© 2018 British Society for Immunology.

Entities:  

Keywords:  Chinese; IL-22; expression; single nucleotide polymorphism; systemic lupus erythematosus

Mesh:

Substances:

Year:  2018        PMID: 29603203      PMCID: PMC6046499          DOI: 10.1111/cei.13133

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus.

Authors:  Bo Yu; Ming Guan; Yinghui Peng; Yong Shao; Chao Zhang; Xupeng Yue; Jie Zhang; Hong Yang; Hejian Zou; Wencai Ye; Jun Wan; Wei Zhang
Journal:  Arthritis Rheum       Date:  2011-11

2.  [Interleukin?22 promotes proliferation of fibroblast?like synoviocytes from patients with rheumatoid arthritis by inducing STAT3 phosphorylation].

Authors:  Jun-Qing Zhu; Ran Wang; Shi-Xian Chen; Di Zhao; Juan Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

Review 3.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

4.  Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.

Authors:  J Lin; L H Yue; W Q Chen
Journal:  Scand J Immunol       Date:  2014-02       Impact factor: 3.487

5.  Impact of IL-22 gene polymorphism on human immunodeficiency virus infection in Han Chinese patients.

Authors:  Jun Hu; Yi Li; Lin Chen; Zhengrong Yang; Guanglu Zhao; Yushu Wang; Jinquan Cheng; Jin Zhao; Ying Peng
Journal:  J Microbiol Immunol Infect       Date:  2014-11-11       Impact factor: 4.399

6.  Interleukin 22 polymorphisms and papillary thyroid cancer.

Authors:  Y G Eun; I H Shin; Y C Lee; S Y Shin; S K Kim; J H Chung; K H Kwon
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

7.  [A study on the relationship between single nucleotide polymorphisms of interleukin-22 and susceptibility to pulmonary tuberculosis].

Authors:  Guang-gui Ding; Guo-liang Zhang; Xin-chun Chen; Ming-xia Zhang; Lin Yang; Zheng Wang
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2012-08

8.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

9.  Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus.

Authors:  Elena Sánchez; Rogelio J Palomino-Morales; Norberto Ortego-Centeno; Juan Jiménez-Alonso; Miguel A González-Gay; Miguel A López-Nevot; Julio Sánchez-Román; Enrique de Ramón; M Francisca González-Escribano; Bernardo A Pons-Estel; Sandra D'Alfonso; Gian Domenico Sebastiani; Marta E Alarcón-Riquelme; Javier Martín
Journal:  Hum Mol Genet       Date:  2009-07-07       Impact factor: 6.150

Review 10.  The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus.

Authors:  Travis Hughes; Amr H Sawalha
Journal:  Arthritis Res Ther       Date:  2011-10-31       Impact factor: 5.156

View more
  8 in total

1.  Identification of LncRNA Linc00513 Containing Lupus-Associated Genetic Variants as a Novel Regulator of Interferon Signaling Pathway.

Authors:  Zhixin Xue; Chaojie Cui; Zhuojun Liao; Shiwei Xia; Pingjing Zhang; Jialin Qin; Qiang Guo; Sheng Chen; Qiong Fu; Zhihua Yin; Zhizhong Ye; Yuanjia Tang; Nan Shen
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

2.  Interaction of miR-181b and IFNA1 Polymorphisms on the Risk of Systemic Lupus Erythematosus.

Authors:  Yong-Ling He; Jun Yang; Zhi-Neng Zeng; Xiang Shi
Journal:  Biomed Res Int       Date:  2020-04-23       Impact factor: 3.411

3.  Lower serum interleukin-22 and interleukin-35 levels are associated with disease status in neuromyelitis optica spectrum disorders.

Authors:  Hong Yang; Lu Han; Yun-Jia Zhou; Jie Ding; Yu Cai; Rong-Hua Hong; Yong Hao; De-Sheng Zhu; Xia-Feng Shen; Yang-Tai Guan
Journal:  CNS Neurosci Ther       Date:  2019-07-24       Impact factor: 5.243

4.  Evaluation of single nucleotide polymorphism in interleukin 22 (IL-22) gene and its association with chronic hepatitis B infection.

Authors:  Paniza Asadi; Seyed Reza Mohebbi; Seyed Masoud Hosseini; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

Review 5.  Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.

Authors:  Xiuyun Xuan; Lin Zhang; Chunxia Tian; Ting Wu; Haihua Ye; Juanmei Cao; Fangqi Chen; Yan Liang; Huilan Yang; Changzheng Huang
Journal:  Cell Biosci       Date:  2021-01-06       Impact factor: 7.133

Review 6.  The Role of T Helper 22 Cells in Dermatological Disorders.

Authors:  Yu Pan; Dan Du; Lian Wang; Xiaoyun Wang; Gu He; Xian Jiang
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

Review 7.  Role of Th22 Cells in the Pathogenesis of Autoimmune Diseases.

Authors:  Qi Jiang; Guocan Yang; Fan Xiao; Jue Xie; Shengjun Wang; Liwei Lu; Dawei Cui
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

8.  Interleukin-22 Polymorphisms in Plasmodium falciparum-Infected Malaria Patients.

Authors:  Nada H Aljarba; Mashael R Al-Anazi; Mohammed I Shafeai; Fuad H Rudiny; Saad M Bin Dajem; Hani Alothaid; Majid Darraj; Saad Alkahtani; Jahad Alghamdi; Mohammed N Al-Ahdal; Ahmed A Al-Qahtani
Journal:  Mediators Inflamm       Date:  2020-02-19       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.